
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [CRSP] CRISPR Therapeutics AG
Data updated 2025-Apr-16 (Wednesday)Compare current performance/technical metrics to history for CRISPR Therapeutics AG. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2025-Apr-16 Wednesday
Day Change | -3.00% Low | Day Volatility | 4.79% Mid |
Streak | ↓ 1 day Mid | % Streak | -3.00% Mid |
RSI | 49 Mid | CCI | 20.4 Mid |
MACD | 0.73 Top | ATR | 2.66 Low |
ADX | 23.3 Mid | SSO | 75.3 Top |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | +8.28% Top | 21.98% Top | -0.11% Mid |
10-day | +10.50% Top | 33.59% Top | +7.04% Top |
20-day | -9.92% Low | 42.21% Top | +2.88% Mid |
50-day | -6.69% Mid | 86.02% Top | -8.15% Mid |
100-day | -19.57% Mid | 86.02% Mid | -11.18% Mid |
200-day | -30.05% Low | 111.98% Low | -18.17% Mid |
Choose Metric type
Select Performance timeframe above to analyze
On 2025-Apr-16, CRISPR Therapeutics AG had:daily change of -3.00% intraday volatility of 4.8% 1 ↓ (down) day streak yielding -3.00% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2025-Apr-16 value annotated for comparison
Related to CRISPR Therapeutics AG
Information for CRISPR Therapeutics AG
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-17 on Google
SEC Reports : Quarterly reports around 2025-Apr-17 on SEC Edgar
Compare CRISPR Therapeutics AG with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes CRISPR Therapeutics AG
Industry : Biotechnology industry performance which includes CRISPR Therapeutics AG